Latest News

Advocacy

HOPA Calls for Appointment of Pharmacy Professionals to Federal COVID-19 Health Equity Task Force

HOPA has joined with 13 other pharmacy organizations to call on the White House to ensure pharmacy professionals are represented in the administration’s newly appointed COVID-19 Health Equity Task Force.

Person recieiving vaccine
Advocacy

5 Guiding Principles of COVID-19 Vaccine Distribution and Administration

HOPA joins the scientific community and public with enthusiasm on the recent historic Emergency Use Authorization approvals for the Pfizer-BioNTech ​and Moderna COVID-19 vaccine​s

Journal Club

Efficacy and Safety of Pembrolizumab in Combination With Bevacizumab and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Ovarian Cancer

These findings suggest that the combination of pembrolizumab with bevacizumab and metronomic cyclophosphamide has clinical activity with a favorable toxicity profile in treatment of recurrent ovarian cancer.

Education

HOPA Launches Core Competency Oncology Pharmacy Program

In the meantime, read about the program and how it prepares pharmacists and others for oncology practice.

HOPA Awards
Membership

Tracelyn Freeman Recipient of HOPA’s Top 10 Trainee Research Award

Tracelyn Freeman, PharmD, PGY2, was presented with HOPA’s Top 10 Trainee Research Award on April 25th for her research poster Hypomethylating Agents with or without Venetoclax in Adult Patients with Acute Myeloid Leukemia. Tracelyn is a Hematology/Oncol

Education

Journal of Hematology Oncology Pharmacy Named Official Publication of the Hematology/Oncology Pharmacy Association

The Lynx Group, a global strategic alliance of medical communications and education companies, is pleased to announce that its Journal of Hematology Oncology Pharmacy™ (JHOP) has been named the official publication of the Hematology/Oncology Pharmacy Asso

Tools and Resources

Our Oral Cancer Collaborative helps hematology/oncology pharmacists stay up to date on Oral Anticancer Agents.

Time to Talk CINVTM Toolkit designed to help facilitate open dialogue between patients and their healthcare teams about common, preventable side effect of chemotherapy